New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin

International Journal of Pharmaceutics

Volumn 325, Issue 1-2, 2006, Pages 2-7

  Nicoli, S ^a   Penna, E ^a   Padula, C ^a   Colombo, P ^a   Santi, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Overactive bladder; Oxybutynin; Rabbit ear skin; Transdermal delivery

Indexed keywords

EUDRAGIT; OXYBUTYNIN; PENETRATION ENHANCING AGENT; PLASTICIZER; PLASTOID; POLYMER; POLYVINYL ALCOHOL; SORBITOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG PENETRATION; DRUG SOLUBILITY; EAR; FILM COATING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EAR; HYDROGEN-ION CONCENTRATION; MANDELIC ACIDS; PARASYMPATHOLYTICS; PERMEABILITY; PLASTICIZERS; POLYVINYL ALCOHOL; RABBITS; SKIN; SKIN ABSORPTION; TISSUE ADHESIVES;

EID: 33750015978     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.06.010     Document Type: Article

References (24)

1. Andersson K.E. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 3 (2004) 46-53
2. Andersson K.E., and Chapple C.R. Oxybutynin and the overactive bladder. World J. Urol. 19 (2001) 319-323
3. Artusi M., Nicoli S., Colombo P., Bettini R., Sacchi A., and Santi P. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J. Pharm. Sci. 93 (2004) 2431-2438
4. Dmochowski R. Improving the tolerability of anticholinergic agents in the treatment of overactive bladder. Drug Saf. 28 (2005) 583-600
5. Dmochowski R.R., Nitti V., Staskin D., Luber K., Appell R., and Davila G.W. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J. Urol. 23 (2005) 263-270
6. Dmochowski R.R., Sand P.K., Zinner N.R., Gittelman M.C., Davila G.W., and Sanders S.W. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 62 (2003) 237-242
7. Femenia-Font A., Padula C., Marra F., Balaguer-Fernandez C., Merino V., Lopez-Castellano A., Nicoli S., and Santi P. Bioadhesive mono-layer film for the in vitro transdermal delivery of sumatriptan. J. Pharm. Sci. 95 (2006) 1561-1569
8. Getsios D., El-Hadi W., Caro I., and Caro J.J. Pharmacological management of overactive bladder: a systematic and critical review of published economic evaluations. Pharmacoeconomics 23 (2005) 995-1006
9. Gupta S.K., and Sathyan G. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J. Clin. Pharmacol. 39 (1999) 289-296
10. Hay-smith J., Herbison P., Ellis G., and Moore K. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst. Rev. (2002) CD003781
11. Hayashi T., Sugibayashi K., and Morimoto Y. Calculation of skin permeability coefficient for ionized and unionized species of indomethacin. Chem. Pharm. Bull. (Tokyo) 40 (1992) 3090-3093
12. Miyamoto E., Kawashima S., Murata Y., Yamada Y., Demizu Y., Knotani H., and Sakai T. Physico-chemical properties of oxybutynin. Analyst 119 (1994) 1489-1492
13. Moser K., Kriwet K., Naik A., Kalia Y.N., and Guy R.H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 52 (2001) 103-112
14. Nicoli S., Amoretti V., Colombo P., and Santi P. Bioadhesive transdermal film containing caffeine. Skin Pharmacol. Physiol. 17 (2004) 119-123
15. Nicoli S., Cappellazzi M., Colombo P., and Santi P. Characterization of the permselective properties of rabbit skin during transdermal iontophoresis. J. Pharm. Sci. 92 (2003) 1482-1488
16. Nicoli S., Colombo P., and Santi P. Release and permeation kinetics of caffeine from bioadhesive transdermal films. AAPS J. 7 (2005) E218-E223
17. Nicoli S., Penna E., Colombo P., and Santi P. Oxybutynin transdermal penetration from bioadhesive films. AAPS J. 6 (2004) Abs M1181
18. Nicoli S., Rimondi S., Colombo P., and Santi P. Physical and chemical enhancement of transdermal delivery of triptorelin. Pharm. Res. 18 (2001) 1634-1637
19. Padula C., Colombo G., Nicoli S., Catellani P.L., Massimo G., and Santi P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J. Control Release 88 (2003) 277-285
20. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
21. Quan, D., Deshpanday, N.A.S.V. C.D., E., 2003. Triacetin as a penetration enhancer for transdermal delivery of a basic drug. USA.
22. Staskin D.R. Overactive bladder in the elderly: a guide to pharmacological management. Drugs Aging 22 (2005) 1013-1028
23. Wein A.J., and Rackley R.R. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J. Urol. 175 (2006) S5-S10
24. Zhai H., and Maibach H.I. Occlusion vs. skin barrier function. Skin. Res. Technol. 8 (2002) 1-6